SLC22A3 and coronary artery disorder: Unlike HMGCR, where SNPs in the locus reduce LDL-C and CAD risk yet increase glycemic burden, SLC22A3 SNPs reduce all three traits (LDL-C, CAD risk and glycemic burden).